Tyverb
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Tyverb, covering 2012-02-16 to 2026-01-06. Get the full timeline:
Most recent: EMA Authorised: Tyverb (lapatinib) — Novartis Europharm Limited
4 regulatory and trial events tracked for Tyverb, covering 2012-02-16 to 2026-01-06. Get the full timeline:
Most recent: EMA Authorised: Tyverb (lapatinib) — Novartis Europharm Limited